Breadcrumb
Seminars 2010 - 2014
“Mechanistic Insights into Dystroglycan Glycosylation and Post-translational Processing”, Duke University Biochemistry Seminar, Durham, NC, October 3, 2014.
“Mechanistic Insights into Muscular Dystrophy Pathogenesis from Bench to Bedside and Back to the Bench Studies”, Texas A&M University Neuroscience Seminar, College Station, TX, September 18, 2014.
“Genetics of dystroglycanopathies: new advances in dystroglycan post-translational processing”, Baylor University College of Medicine Seminar, Houston, TX, September 9, 2014.
“Mechanistic Insights into Muscular Dystrophy from Bench to Bedside and Back to the Bench Studies”, UCLA Neurology Grand Rounds, University of California, Los Angeles, CA, April 9, 2014
"Mechanistic Insights into Dystroglycan Glycosylation from Bench to Bedside and Back to the Bench Studies," Pediatrics Frontiers in Research seminar, University of Iowa, Iowa City, IA, February 24, 2014.
"Mechanistic Insights into Dystroglycan Glycosylation and Muscular Dystrophy," Cincinnati Children's Heart Institute Seminar Series, Cincinnati, OH, February 10, 2014.
"Mechanistic Insights into Muscular Dystrophy Pathogenesis from Bench to Bedside and Back to the Bench Studies," University of Georgia, Athens, GA, December 4, 2013.
"Mechanistic Insights into Muscular Dystrophy Pathogenesis from Bench to Bedside and Back to the Bench Studies," Cornell Physiology Biophysics and Systems Biology Seminar Series, New York, NY, October 28, 2013.
"Mechanistic Insights into Dystroglycan Glycosylation and Muscular Dystrophy," EMBO Workshop on Muscle Wasting, Ascona, Switzerland, September 19, 2013.
"Novel Glycosylation Required for Skeletal Muscle Function," John and Margaret Faulkner Lectureship, University of Michigan, Ann Arbor, MI, June 19, 2013.
"Mechanistic Insights into Muscular Dystrophy Pathogenesis from Bench to Bedside and Back to the Bench Studies," Segawa Neurological Clinic for Children Symposium, Tokyo, Japan, June 2, 2013.
"Patient fibroblast alpha-dystroglycan glycosylation studies: A versatile tool for developing therapies to treat dystroglycanopathies," The 55th Annual Meeting of the Japanese Society of Child Neurology, Oita, Japan, May 31, 2013.
"Fukuyama congenital muscular dystrophy," The 55th Annual Meeting of the Japanese Society of Child Neurology, Oita, Japan, May 30, 2013.
"Novel Glycosylation Enzymes Required for Dystroglycan Function as an Extracellular Matrix Receptor," Dept. of Biological Chemistry Seminar Program, Johns Hopkins University, Baltimore, MD, May 21, 2013.
"Molecular insights into the pathogenesis of glycosylation-deficient muscular dystrophy," Johnson-Sokatch Lectureship, University of Oklahoma, Oklahoma City, OK, May 15, 2013.
"Molecular Basis for Dystroglycan Binding to Laminin-G Domain-Containing Ligands," ASBMB Annual Meeting, Boston, MA, April 21, 2013.
"Dystroglycan Function Requires Xylosyltransferase and Glucuronyltransferase Activities of LARGE," Glycosylation Workshop, Charlotte NC, April 18, 2013.
"Genetics and Glycobiology of Dystroglycanopathies," Gordon Glycobiology Research Conference, Ventura, CA, March 6, 2013.
"Development of the Iowa Wellstone Muscular Dystrophy Center: From Bench to Bedside and Back to the Bench." Center for Muscle Biology Fall Retreat, University of Kentucky, Lexington, KY, October 25, 2012.
“Mechanistic Insights into Muscular Dystrophy Pathogenesis from Bench to Bedside and Back to the Bench Studies," College of Medicine Dean's Distinguished Lecture, University of Kentucky, Lexington, KY, October 24, 2012.
Panel Discussion: Disease Pathogenesis, Wellstone Centers Meeting, Watertown, MA, October 18, 2012.
“Patient fibroblast functional complementation studies: A valuable tool in the identification of novel Walker Warburg syndrome disease genes, " World Muscle Society Meeting, Perth, Australia, October 10, 2012.
"Novel Glycosylation Pathways Required for Dystroglycan Function," Duke University, Durham, NC, September 20, 2012.
“Molecular basis for dystroglycan binding to the muscle basal lamina” Institut Pasteur, Paris, France, July 2, 2012.
Preclinical Work - Research Updates, Congenital Muscle Disease Forum - satellite meeting, New Directions in Biology and Disease of Skeletal Muscle Conference, New Orleans, LA, June 19, 2012.
"Molecular basis for dystroglycan binding to the muscle basal lamina" Frontiers in Myogenesis Meeting, New York, NY, June 6, 2012.
“Mechanistic and Molecular Insights into the Pathogenesis of Muscular Dystrophy,” Yeshiva University, Einstein College of Medicine, Bronx, NY, May 4, 2012.
“Mechanistic and Molecular Insights into the Pathogenesis of Muscular Dystrophy,” University of Nebraska-Lincoln, Lincoln, NE, April 25, 2012.
"Mechanistic and Molecular Insights into Dystroglycan Glycosylation,” CMD: Exploring the Role of Myomatrix, Reno, NV, April 24, 2012.
“Mechanistic and Molecular Insights into the Pathogenesis of Muscular Dystrophy,” Iowa State University, Ames, IA, March 27, 2012.
"Animal models and how they have contributed to our knowledge of the disease pathogenesis” and “LARGE up-regulation,” ENMC Dystroglycan and Dystroglycanopathies Workshop, Naarden, The Netherlands, November 12-13, 2011.
“Mechanistic and Molecular Insights into the Pathogenesis of Muscular Dystrophy,” Kurt Ebner Discovery Lecture, Kansas City, KS, October 31, 2011.
"Dysferlin and Muscle Membrane Repair,” Coalition to Cure Calpain3 LGMD2A Workshop, Santa Monica, CA, October 27, 2011.
“Genetics and Molecular Pathogenesis of Dystroglycanopathies,” Wellstone Muscular Dystrophy Cooperative Research Center meeting, Columbus, OH, October 14, 2011.
"Role of Glycosylation in Muscle Dystrophies,” International Conference on Muscle Wasting, Ascona, Switzerland, September 22, 2011.
“Glycobiology and Cell-Matrix Interactions: Insights from Dystroglycan Function,” Gordon Research Conference on Collagen, New London, NH, July 21, 2011.
“Mechanistic and Molecular Insights into the Pathogenesis of Glycosylation-Deficient Muscular Dystrophy,” AANP Annual Meeting, Presidential Symposium, Seattle, WA, June 26, 2011.
“Mechanistic and molecular insights into the pathogenesis of muscular dystrophy,” Nationwide Children’s Hospital, The Ohio State University, Columbus, OH, June 2, 2011.
“Mechanistic and Molecular Insights into the Pathogenesis of Muscular Dystrophy,” The Sanford-Burnham Medical Research Institute, La Jolla, CA, April 26, 2011.
“Dystrophin-Glycoprotein Complex and Molecular Pathogenesis of Duchenne Muscular Dystrophy,” 1st Chinese Conference on Translational Research in Duchenne Muscular Dystrophy, Guangzhou, China, April 7, 2011.
“Mechanistic and Molecular Insights into the Pathogenesis of Muscular Dystrophy,” University of California San Francisco, Gladstone Institute, San Francisco, CA, March 21, 2011.
“Mechanistic and Molecular Insights into the Pathogenesis of Muscular Dystrophy,” University of California Davis, Davis, CA, March 3, 2011.
“Molecular Basis of Glycosylation-deficient Muscular Dystrophy and Approaches to Therapy,” Sanford-Burnham Rare Disease Symposium, La Jolla, CA, February 25, 2011.
University of California San Diego, Glycobiology Symposium, San Diego, CA, February 18, 2011.
“Mechanistic and Molecular Insights into the Pathogenesis of Muscular Dystrophy,” University of California San Diego, San Diego, CA, February 17, 2011.
“Mechanistic and Molecular Insights into the Pathogenesis of Muscular Dystrophy,” NGM Biopharmaceuticals, Inc., San Francisco, CA, January 26, 2011.
“Glycosylation and Dystroglycan Function in Congenital Muscular Dystrophy,” Children's National Medical Center, December 2, 2010.
“Distinct Functions of Glial and Neuronal Dystroglycan in the Developing and Adult Mouse Brain,” LGMD-CMD Meeting, Charlotte, NC, November 11, 2010.
“Mechanistic and Molecular Insights into the Pathogenesis of Muscular Dystrophy,” University of Texas Southwestern, Dallas, TX, November 3, 2010.
“Novel Post-Translational Processing of Dystroglycan: Insights from Muscular Dystrophy Patients,” ASMB meeting, October 24, 2010.
“Mechanistic and Molecular Insights into the Pathogenesis of Muscular Dystrophy,” University of Wisconsin, Cardiovascular Research Conference, Madison, WI, September 21, 2010.
“Mechanistic and Molecular Insights into the Pathogenesis of Muscular Dystrophy,” XII International Congress on Neuromuscular Diseases, Naples, Italy, July 22, 2010.
“Molecular Basis of Glycosylation-deficient Muscular Dystrophy and Approaches to Therapy,” University of Texas Health Science Center – Houston, Institute of Molecular Medicine, Houston, TX, June 25, 2010.
“Mechanistic and Molecular Insights into the Pathogenesis of Muscular Dystrophy,” University of Minnesota, Lillehei Heart Institute, Minneapolis, MN, June 9, 2010.
“Mechanistic and Molecular Insights into the Pathogenesis of Muscular Dystrophy,” University of Nebraska Medical Center, Omaha, NE, June 8, 2010.
“Mechanistic and Molecular Insights into Fatigue in Muscular Dystrophy,” Ottawa Conference on New Directions in Biology & Disease in Skeletal Muscle, Ottawa, Ontario, Canada, May 5, 2010.
“Novel Post-Translational Processing of Dystroglycan: Insights from Muscular Dystrophy Patients,” University of Georgia, Athens, GA, April 23, 2010.
“Molecular Basis of Glycosylation-deficient Muscular Dystrophy and Approaches to Therapy,” Genzyme Corp., Framingham, MA, April 2, 2010.
“Novel Post-Translational Processing of Dystroglycan: Insights from Muscular Dystrophy Patients,” Loyola University Chicago, Chicago, IL, March 31, 2010.
“Novel Post-Translational Processing of Dystroglycan: Insights from Muscular Dystrophy Patients,” University of California Santa Barbara, Santa Barbara, CA, February 25, 2010.
"Current Understanding of Dysferlin and Membrane Repair", ENMC Workshop on Dysferlinopathy, Naarden, The Netherlands, January 30, 2010.